Jackson D. Harvey

Jackson D. Harvey

Auto-generated profile, based on publicly available information

Jackson D. Harvey

Memorial Sloan Kettering Cancer Center

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 March 2017 in Nature Biomedical Engineering
Verified
Journal Article
Closed access
PDF file
JHJackson D. Harvey
Jackson D. Harvey
PJPrakrit V. Jena
Prakrit V. Jena
HBHanan A. Baker
Hanan A. Baker
GZGül H. Zerze
Gül H. Zerze
RWRyan M. Williams
Ryan M. Williams
DHDaniel A. Heller
Daniel A. Heller

6 April 2018 in Science Advances
Verified
Journal Article
Open access
PDF file
RWRyan Williams
Ryan Williams
CLChristopher Lee
Christopher Lee
TGThomas V. Galassi
Thomas V. Galassi
JHJackson D. Harvey
Jackson D. Harvey
RLRachel Leicher
Rachel Leicher
DHDaniel A. Heller
Daniel A. Heller
Ovarian cancer biomarker detection using a novel nanosensor implant in live mice.

23 August 2012 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
MAMichael D Alpert
Michael D Alpert
JHJackson D Harvey
Jackson D Harvey
WLW Anderson Lauer
W Anderson Lauer
RRR Keith Reeves
R Keith Reeves
MPMichael Piatak
Michael Piatak
DEDavid T Evans
David T Evans
Live-attenuated strains of simian immunodeficiency virus (SIV) routinely confer apparent sterilizing immunity against pathogenic SIV challenge in rhesus macaques. Understanding the mechanisms of protection by live-attenuated SIV may provide important insights into the immune responses needed for protection against HIV-1. Here we investigated the development of antibodies that are functional against neutralization-resistant SIV challenge strains, and tested the hypothesis that these antibodies are associated with protection. In the absence of detectable neutralizing antibodies, Env-specific antibody-dependent cell-mediated cytotoxicity (ADCC) emerged by three weeks after inoculation with SIVΔnef, increased progressively over time, and was proportional to SIVΔnef replication. Persistent infection with SIVΔnef elicited significantly higher ADCC titers than immunization with a non-persistent SIV strain that is limited to a single cycle of infection. ADCC titers were higher against viruses matched to the vaccine strain in Env, but were measurable against viruses expressing heterologous Env proteins. In two separate experiments, which took advantage of either the strain-specificity or the time-dependent maturation of immunity to overcome complete protection against SIVmac251 challenge, measures of ADCC activity were higher among the SIVΔnef-inoculated macaques that remained uninfected than among those that became infected. These observations show that features of the antibody response elicited by SIVΔnef are consistent with hallmarks of protection by live-attenuated SIV, and reveal an association between Env-specific antibodies that direct ADCC and apparent sterilizing protection by SIVΔnef. Live-attenuated vaccines can prevent simian immunodeficiency virus (SIV) infection upon experimental challenge of rhesus macaques. Although safety considerations preclude vaccinating humans with live-attenuated HIV-1, it may be possible to replicate the types of immunity induced by live-attenuated SIV through an alternative approach. Thus, identifying the immune responses underlying protection by live-attenuated SIV and understanding their induction would provide guidance for HIV-1 vaccine design. An important role for the maturation of virus-specific antibody responses could explain the time-dependent development of protection by live-attenuated SIV. However, antibodies that block the entry of the challenge virus into cells are usually undetectable. Antibodies can also direct the killing of virus-infected cells by antibody-dependent cell-mediated cytotoxicity (ADCC). Here we show that live-attenuated SIV induces progressive increases in ADCC over time, and that the development of these antibodies is dependent upon the persistent replication of the vaccine strain. In two different experiments, the animals immunized with live-attenuated SIV that remained uninfected after pathogenic SIV challenge had higher measures of ADCC than those that became infected. Our results suggest that antibodies contribute to protection by live-attenuated SIV, and that persistent stimulation of antibody responses may be essential for HIV-1 vaccines to induce high ADCC activity.

12 September 2017 in ACS Nano
Verified
Journal Article
Open access
PJPrakrit V. Jena
Prakrit V. Jena
DRDaniel Roxbury
Daniel Roxbury
TGThomas V. Galassi
Thomas V. Galassi
LALeila Akkari
Leila Akkari
CHChristopher P. Horoszko
Christopher P. Horoszko
DHDaniel A. Heller
Daniel A. Heller
Lipid accumulation within the lumen of endolysosomal vesicles is observed in various pathologies including atherosclerosis, liver disease, neurological disorders, lysosomal storage disorders, and cancer. Current methods cannot measure lipid flux specifically within the lysosomal lumen of live cells. We developed an optical reporter, composed of a photoluminescent carbon nanotube of a single chirality, that responds to lipid accumulation via modulation of the nanotube’s optical band gap. The engineered nanomaterial, composed of short, single-stranded DNA and a single nanotube chirality, localizes exclusively to the lumen of endolysosomal organelles without adversely affecting cell viability or proliferation or organelle morphology, integrity, or function. The emission wavelength of the reporter can be spatially resolved from within the endolysosomal lumen to generate quantitative maps of lipid content in live cells. Endolysosomal lipid accumulation in cell lines, an example of drug-induced phospholipidosis, was observed for multiple drugs in macrophages, and measurements of patient-derived Niemann–Pick type C fibroblasts identified lipid accumulation and phenotypic reversal of this lysosomal storage disease. Single-cell measurements using the reporter discerned subcellular differences in equilibrium lipid content, illuminating significant intracellular heterogeneity among endolysosomal organelles of differentiating bone-marrow-derived monocytes. Single-cell kinetics of lipoprotein-derived cholesterol accumulation within macrophages revealed rates that differed among cells by an order of magnitude. This carbon nanotube optical reporter of endolysosomal lipid content in live cells confers additional capabilities for drug development processes and the investigation of lipid-linked diseases.

15 November 2012 in Journal of Virology
Verified
Journal Article
Open access
MAMichael D. Alpert
Michael D. Alpert
LHLisa N. Heyer
Lisa N. Heyer
DWDavid E. J. Williams
David E. J. Williams
JHJackson D. Harvey
Jackson D. Harvey
TGThomas Greenough
Thomas Greenough
DEDavid T. Evans
David T. Evans
The resistance of human immunodeficiency virus type 1 (HIV-1) to antibody-mediated immunity often prevents the detection of antibodies that neutralize primary isolates of HIV-1. However, conventional assays for antibody functions other than neutralization are suboptimal. Current methods for measuring the killing of virus-infected cells by antibody-dependent cell-mediated cytotoxicity (ADCC) are limited by the number of natural killer (NK) cells obtainable from individual donors, donor-to-donor variation, and the use of nonphysiological targets. We therefore developed an ADCC assay based on NK cell lines that express human or macaque CD16 and a CD4+T-cell line that expresses luciferase from a Tat-inducible promoter upon HIV-1 or simian immunodeficiency virus (SIV) infection. NK cells and virus-infected targets are mixed in the presence of serial plasma dilutions, and ADCC is measured as the dose-dependent loss of luciferase activity. Using this approach, ADCC titers were measured in plasma samples from HIV-infected human donors and SIV-infected macaques. For the same plasma samples paired with the same test viruses, this assay was approximately 2 orders of magnitude more sensitive than optimized assays for neutralizing antibodies—frequently allowing the measurement of ADCC in the absence of detectable neutralization. Although ADCC correlated with other measures of Env-specific antibodies, neutralizing and gp120 binding titers did not consistently predict ADCC activity. Hence, this assay affords a sensitive method for measuring antibodies capable of directing ADCC against HIV- or SIV-infected cells expressing native conformations of the viral envelope glycoprotein and reveals incomplete overlap of the antibodies that direct ADCC and those measured in neutralization and binding assays.

6 May 2019 in ACS Sensors
Verified
Journal Article
Closed access
JHJackson D. Harvey
Jackson D. Harvey
HBHanan Baker
Hanan Baker
MOMichael V. Ortiz
Michael V. Ortiz
AKAlex Kentsis
Alex Kentsis
DHDaniel A. Heller
Daniel A. Heller